{"transactions":[{"id":2670394,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2021-06-14T17:17:36.000Z","date":"2021-06-14","kind":"purchase","acquired":true,"shares":8097166,"price":2.47,"value":20000000.02,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share.  The Warrant is exercisable at any time and from time to time prior to June 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share.  The Warrant is exercisable at any time and from time to time prior to June 14, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share.  The Warrant is exercisable at any time and from time to time prior to June 14, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP.  Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC.  Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":8097166,"derivative":{"exercise_price":2.84,"exercise_date":"2021-06-14","expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":8097166},"source":{"system":"sec-edgar","filing":"0000899243-21-023629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924321023629/doc4.xml","form_type":"4"}},{"id":2670393,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T17:17:36.000Z","date":"2021-06-14","kind":"purchase","acquired":true,"shares":8097166,"price":2.47,"value":20000000.02,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP.  Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC.  Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":36396907,"source":{"system":"sec-edgar","filing":"0000899243-21-023629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924321023629/doc4.xml","form_type":"4"}},{"id":2683650,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T16:41:27.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":961807,"price":2.86,"value":2750768.02,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 961,807 shares of the Issuer's common stock are held directly by Athyrium Opportunities III Co-Invest 1 LP.  Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC. Jeffrey A. Ferrell is the President of Athyrium Opportunities Associates Co-Invest LLC and the managing member of Athyrium Funds GP Holdings, LLC."}],"balance_after":28299741,"source":{"system":"sec-edgar","filing":"0000899243-21-021805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924321021805/doc4.xml","form_type":"4"}},{"id":2683649,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T16:41:27.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":306308,"price":2.86,"value":876040.88,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The 306,308 shares of the Issuer's common stock are directly owned by Athyrium Opportunities III Acquisition LP.  Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC.  Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":28299741,"source":{"system":"sec-edgar","filing":"0000899243-21-021805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924321021805/doc4.xml","form_type":"4"}},{"id":2952035,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"7.25% Convertible Senior Notes due 2025","published_at":"2020-12-09T17:35:11.000Z","date":"2020-12-07","kind":"purchase","acquired":false,"shares":78500000,"price":78500000,"value":6.16225e+15,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The 7.25% Convertible Senior Notes due 2025 (the \"Convertible Notes\") are convertible into shares of the Issuer's common stock at an initial conversion rate of 278.0094 shares per $1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $3.60 per share."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Athyrium Opportunities III Co-Invest 1 LP acquired such Convertible Notes in exchange for the discharge of amounts outstanding under the Issuer's credit and security agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The $78,500,000 aggregate principal amount of Convertible Notes is held directly by Athyrium Opportunities III Co-Invest 1 LP.  Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC. Jeffrey A. Ferrell is the President of Athyrium Opportunities Associates Co-Invest LLC and the managing member of Athyrium Funds GP Holdings, LLC."}],"balance_after":78500000,"derivative":{"exercise_date":"2021-01-06","expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":21823737},"source":{"system":"sec-edgar","filing":"0000899243-20-033184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320033184/doc4.xml","form_type":"4"}},{"id":2952034,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"7.25% Convertible Senior Notes due 2025","published_at":"2020-12-09T17:35:11.000Z","date":"2020-12-07","kind":"purchase","acquired":false,"shares":25000000,"price":25000000,"value":625000000000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The 7.25% Convertible Senior Notes due 2025 (the \"Convertible Notes\") are convertible into shares of the Issuer's common stock at an initial conversion rate of 278.0094 shares per $1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $3.60 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The $25,000,000 aggregate principal amount of Convertible Notes is held directly by Athyrium Opportunities III Acquisition LP.  Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC.  Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC."}],"balance_after":25000000,"derivative":{"exercise_date":"2021-01-06","expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":6950235},"source":{"system":"sec-edgar","filing":"0000899243-20-033184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320033184/doc4.xml","form_type":"4"}},{"id":2952033,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":5,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":6,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85049,"kind":"person","name":"Athyrium Opportunities III Acquisition LP","position":7,"cik":"0001835266","reported_name":"Athyrium Opportunities III Acquisition LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":8,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":9,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T17:35:11.000Z","date":"2020-12-07","kind":"purchase","acquired":true,"shares":4128440,"price":3.27,"value":13499998.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The 4,128,440 shares of the Issuer's common stock are directly owned by Athyrium Opportunities III Acquisition 2 LP.  Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.  Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC.  Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":26991626,"source":{"system":"sec-edgar","filing":"0000899243-20-033184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320033184/doc4.xml","form_type":"4"}},{"id":3100016,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":5,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":6,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":7,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":8,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-06-25T16:25:56.000Z","date":"2020-06-23","kind":"exercise","acquired":false,"shares":101736263,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The 4,211,977, 2,329,083, 7,603,040 and 4,175,753 shares of the Issuer's common stock issued on the conversion of the Series B Preferred Stock upon the closing of the initial public offering of the Issuer's common stock are held by Athyrium Opportunities Fund (A) LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities III Acquisition 2 LP and Athyrium Opportunities III Co-Invest 1 LP, respectively. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"(continued from footnote 5) Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates GP LLC is the general partner of Athyrium Opportunities Associates LP, which is the general partner of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Opportunities Advisers LLC is the investment adviser of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Capital Management, LP is a member of Athyrium Opportunities Associates GP LLC and an investment sub-adviser of Athyrium Opportunities Advisers LLC. NB Alternatives GP Holdings LLC is also a member of Athyrium Opportunities Associates GP LLC. NB Alternatives Holdings LLC is the sole member of NB Alternatives GP Holdings LLC and is a member of NB Alternatives Advisers LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"(continued from footnote 6) NB Alternatives Advisers LLC is the sole member of Athyrium Opportunities Advisers LLC. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC and Athyrium Opportunities Associates III GP LLC. Athyrium Capital Holdings, LLC is the general partner of Athyrium Capital Management, LP. Jeffrey A. Ferrell is the managing member of Athyrium Capital Holdings, LLC and Athyrium Funds GP Holdings, LLC and the President of Athyrium Capital Management, LP, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities Associates III GP LLC, and Athyrium Opportunities Associates GP LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18319853},"source":{"system":"sec-edgar","filing":"0000899243-20-017653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320017653/doc4.xml","form_type":"4"}},{"id":3100015,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":5,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":6,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":7,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":8,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Unsecured Convertible Promissory Note","published_at":"2020-06-25T16:25:56.000Z","date":"2020-06-23","kind":"exercise","acquired":false,"reported_value":15000000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0000899243-20-017653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320017653/doc4.xml","form_type":"4"}},{"id":3100014,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":5,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":6,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":7,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":8,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-25T16:25:56.000Z","date":"2020-06-23","kind":"exercise","acquired":true,"shares":18319853,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The 4,211,977, 2,329,083, 7,603,040 and 4,175,753 shares of the Issuer's common stock issued on the conversion of the Series B Preferred Stock upon the closing of the initial public offering of the Issuer's common stock are held by Athyrium Opportunities Fund (A) LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities III Acquisition 2 LP and Athyrium Opportunities III Co-Invest 1 LP, respectively. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"(continued from footnote 5) Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates GP LLC is the general partner of Athyrium Opportunities Associates LP, which is the general partner of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Opportunities Advisers LLC is the investment adviser of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Capital Management, LP is a member of Athyrium Opportunities Associates GP LLC and an investment sub-adviser of Athyrium Opportunities Advisers LLC. NB Alternatives GP Holdings LLC is also a member of Athyrium Opportunities Associates GP LLC. NB Alternatives Holdings LLC is the sole member of NB Alternatives GP Holdings LLC and is a member of NB Alternatives Advisers LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"(continued from footnote 6) NB Alternatives Advisers LLC is the sole member of Athyrium Opportunities Advisers LLC. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC and Athyrium Opportunities Associates III GP LLC. Athyrium Capital Holdings, LLC is the general partner of Athyrium Capital Management, LP. Jeffrey A. Ferrell is the managing member of Athyrium Capital Holdings, LLC and Athyrium Funds GP Holdings, LLC and the President of Athyrium Capital Management, LP, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities Associates III GP LLC, and Athyrium Opportunities Associates GP LLC."}],"balance_after":23303346,"source":{"system":"sec-edgar","filing":"0000899243-20-017653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320017653/doc4.xml","form_type":"4"}},{"id":3100013,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":5,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":6,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":7,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":8,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-25T16:25:56.000Z","date":"2020-06-23","kind":"exercise","acquired":true,"shares":1250000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":23303346,"source":{"system":"sec-edgar","filing":"0000899243-20-017653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320017653/doc4.xml","form_type":"4"}},{"id":3100012,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":104496,"kind":"organization","name":"Athyrium Capital Management, LP","position":1,"cik":"0001728001","reported_name":"Athyrium Capital Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85052,"kind":"person","name":"Ferrell Jeffrey","position":2,"cik":"0001394967","reported_name":"Ferrell Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138303,"kind":"organization","name":"Athyrium Capital Holdings, LLC","position":3,"cik":"0001815216","reported_name":"Athyrium Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85054,"kind":"person","name":"Athyrium Funds GP Holdings LLC","position":4,"cik":"0001815225","reported_name":"Athyrium Funds GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138305,"kind":"organization","name":"Athyrium Opportunities Advisers LLC","position":5,"cik":"0001815484","reported_name":"Athyrium Opportunities Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76353,"kind":"organization","name":"NB ALTERNATIVES ADVISERS LLC","position":6,"cik":"0001469000","reported_name":"NB Alternatives Advisers LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138306,"kind":"organization","name":"NB Alternatives GP Holdings LLC","position":7,"cik":"0001815407","reported_name":"NB Alternatives GP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138304,"kind":"organization","name":"NB Alternatives Holdings LLC","position":8,"cik":"0001815501","reported_name":"NB Alternatives Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-25T16:25:56.000Z","date":"2020-06-23","kind":"purchase","acquired":true,"shares":3333333,"price":15,"value":49999995.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":23303346,"source":{"system":"sec-edgar","filing":"0000899243-20-017653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815484/000089924320017653/doc4.xml","form_type":"4"}}]}